Insider Transactions in Q1 2023 at Bei Gene, Ltd. (BGNE)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 16
2023
|
Xiaodong Wang Director |
SELL
Bona fide gift
|
Direct |
67,444
-1.22%
|
-
|
Mar 08
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
67,635
-28.82%
|
$15,217,875
$225.59 P/Share
|
Mar 08
2023
|
Xiaodong Wang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67,635
+50.0%
|
$0
$0.13 P/Share
|
Mar 01
2023
|
Julia Aijun Wang Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
343
-100.0%
|
$82,320
$240.21 P/Share
|
Jan 12
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Indirect |
5,000
-90.99%
|
$1,300,000
$260.9 P/Share
|
Jan 11
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
2,500
-63.21%
|
$630,000
$252.55 P/Share
|
Jan 10
2023
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
13,594
-56.73%
|
$3,371,312
$248.72 P/Share
|
Jan 10
2023
|
John Oyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,797
-56.73%
|
$1,685,656
$248.72 P/Share
|
Jan 10
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
1,600
-100.0%
|
$400,000
$250.09 P/Share
|
Jan 09
2023
|
Xiaodong Wang Director |
SELL
Open market or private sale
|
Direct |
900
-100.0%
|
$225,000
$250.0 P/Share
|